Thyrocare Technologies Limited (NSE:THYROCARE)
467.00
-2.05 (-0.44%)
May 22, 2026, 3:30 PM IST
Thyrocare Technologies Revenue
In the fiscal year ending March 31, 2026, Thyrocare Technologies had annual revenue of 8.29B INR with 20.61% growth. Thyrocare Technologies had revenue of 2.24B in the quarter ending March 31, 2026, with 19.66% growth.
Revenue
8.29B
Revenue Growth
+20.61%
P/S Ratio
8.95
Revenue / Employee
4.55M
Employees
1,822
Market Cap
74.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 8.29B | 1.42B | 20.61% |
| Mar 31, 2025 | 6.87B | 1.15B | 20.19% |
| Mar 31, 2024 | 5.72B | 452.20M | 8.59% |
| Mar 31, 2023 | 5.27B | -621.90M | -10.56% |
| Mar 31, 2022 | 5.89B | 942.40M | 19.05% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 604.34B |
| Cipla | 277.12B |
| Apollo Hospitals Enterprise | 252.29B |
| Divi's Laboratories | 103.14B |
| Akums Drugs and Pharmaceuticals | 43.59B |
| Sun Pharma Advanced Research Company | 18.90B |
| Aarti Pharmalabs | 18.01B |
| Yatharth Hospital & Trauma Care Services | 10.95B |
Thyrocare Technologies News
- 11 days ago - Thyrocare Technologies Ltd (BOM:539871) Q4 2026 Earnings Call Highlights: Strong Revenue Growth ... - GuruFocus
- 16 days ago - Thyrocare shares jump over 11% after Q4 results; Net profit surges 117% to Rs 47.1 crore, revenue up 19.7% - Business Upturn
- 2 months ago - Thyrocare Technologies receives Rs 2 crore tax demand notice for FY 2024-25 - Business Upturn
- 4 months ago - Thyrocare Technologies shares fall sharply over 4% today despite strong Q3 FY26 results - Business Upturn
- 4 months ago - Thyrocare Technologies Ltd (BOM:539871) Q3 2026 Earnings Call Highlights: Robust Revenue Growth ... - GuruFocus
- 4 months ago - Q3 2026 Thyrocare Technologies Ltd Earnings Call Transcript - GuruFocus
- 7 months ago - Thyrocare shares jump over 11% after strong Q2 results; Approves bonus issue in 2:1 ratio - Business Upturn
- 7 months ago - Thyrocare Technologies Ltd (BOM:539871) Q2 2026 Earnings Call Highlights: Strong Revenue Growth ... - GuruFocus